Applications and prospects of targeted therapy for neuroblastoma

被引：4

作者：

Wang, Jing ^{[1
]}

Yao, Wei ^{[1
]}

Li, Kai ^{[1
]}

机构：

[1] Fudan Univ, Dept Pediat Surg, Childrens Hosp, Shanghai, Peoples R China

来源：

WORLD JOURNAL OF PEDIATRIC SURGERY | 2020年 / 3卷 / 02期

关键词：

pediatrics; therapeutics; ANTI-GD2; MONOCLONAL-ANTIBODY; HIGH-RISK NEUROBLASTOMA; PHASE-I TRIAL; ALK; DISEASE; MYCN; I-131-METAIODOBENZYLGUANIDINE; CHEMOTHERAPY; COMBINATION; SURVIVAL;

D O I：

10.1136/wjps-2020-000164

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

BackgroundNeuroblastoma is an extremely malignant tumor in children. For advanced or recurrent cases, existing treatment modalities are limited and efficacy remains disappointing. With the improvement in understanding of molecular biology of neuroblastoma and the development of clinical trials of targeted drug therapy, a variety of targeted therapies for neuroblastoma have appeared.Data sourcesAll the recent literatures on targeted therapies of neuroblastoma on PubMed were searched and reviewed.ResultsThis article reviewed targeted therapies of neuroblastoma going through clinical trials and obtained preliminary results. The features, advantages and disadvantages of targeted radiation therapy,immunotherapy, gene and pathway molecular inhibitor and angiogenesis inhibitor were discussed.ConclusionThis study provides references for better understanding the current progress of targeted therapies for neuroblastoma.

引用

页数：6

共 54 条

[1] The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma [J].

Berry, Teeara ;

Luther, William ;

Bhatnagar, Namrata ;

Jamin, Yann ;

Poon, Evon ;

Sanda, Takaomi ;

Pei, Desheng ;

Sharma, Bandana ;

Vetharoy, Winston R. ;

Hallsworth, Albert ;

Ahmad, Zai ;

Barker, Karen ;

Moreau, Lisa ;

Webber, Hannah ;

Wang, Wenchao ;

Liu, Qingsong ;

Perez-Atayde, Antonio ;

Rodig, Scott ;

Cheung, Nai-Kong ;

Raynaud, Florence ;

Hallberg, Bengt ;

Robinson, Simon P. ;

Gray, Nathanael S. ;

Pearson, Andrew D. J. ;

Eccles, Suzanne A. ;

Chesler, Louis ;

George, Rani E. .

CANCER CELL, 2012, 22 (01) :117-130

[2] ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma [J].

Bresler, Scott C. ;

Weiser, Daniel A. ;

Huwe, Peter J. ;

Park, Jin H. ;

Krytska, Kateryna ;

Ryles, Hannah ;

Laudenslager, Marci ;

Rappaport, Eric F. ;

Wood, Andrew C. ;

McGrady, Patrick W. ;

Hogarty, Michael D. ;

London, Wendy B. ;

Radhakrishnan, Ravi ;

Lemmon, Mark A. ;

Mosse, Yael P. .

CANCER CELL, 2014, 26 (05) :682-694

[3] Differential Inhibitor Sensitivity of Anaplastic Lymphoma Kinase Variants Found in Neuroblastoma [J].

Bresler, Scott C. ;

Wood, Andrew C. ;

Haglund, Elizabeth A. ;

Courtright, Joshua ;

Belcastro, Lili T. ;

Plegaria, Jefferson S. ;

Cole, Kristina ;

Toporovskaya, Yana ;

Zhao, Huaqing ;

Carpenter, Erica L. ;

Christensen, James G. ;

Maris, John M. ;

Lemmon, Mark A. ;

Mosse, Yael P. .

SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (108)

[4] Targeting ALK in neuroblastoma-preclinical and clinical advancements [J].

Carpenter, Erica L. ;

Mosse, Yael P. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (07) :391-399

[5]

Castellani MR, 2000, Q J NUCL MED, V44, P77

[6] Oncogenic mutations of ALK kinase in neuroblastoma [J].

Chen, Yuyan ;

Takita, Junko ;

Choi, Young Lim ;

Kato, Motohiro ;

Ohira, Miki ;

Sanada, Masashi ;

Wang, Lili ;

Soda, Manabu ;

Kikuchi, Akira ;

Igarashi, Takashi ;

Nakagawara, Akira ;

Hayashi, Yasuhide ;

Mano, Hiroyuki ;

Ogawa, Seishi .

NATURE, 2008, 455 (7215) :971-U56

[7] Bone Marrow Minimal Residual Disease Was an Early Response Marker and a Consistent Independent Predictor of Survival After Anti-GD2 Immunotherapy [J].

Cheung, Nai-Kong V. ;

Ostrovnaya, Irina ;

Kuk, Deborah ;

Cheung, Irene Y. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07) :755-763

[8] Neuroblastoma: developmental biology, cancer genomics and immunotherapy [J].

Cheung, Nai-Kong V. ;

Dyer, Michael A. .

NATURE REVIEWS CANCER, 2013, 13 (06) :397-411

[9] Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo [J].

Cheung, Nai-Kong V. ;

Guo, Hongfen ;

Hu, Jian ;

Tassev, Dimiter V. ;

Cheung, Irene Y. .

ONCOIMMUNOLOGY, 2012, 1 (04)

[10] Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification [J].

De Brouwer, Sara ;

De Preter, Katleen ;

Kumps, Candy ;

Zabrocki, Piotr ;

Porcu, Michael ;

Westerhout, Ellen M. ;

Lakeman, Arjan ;

Vandesompele, Jo ;

Hoebeeck, Jasmien ;

Van Maerken, Tom ;

De Paepe, Anne ;

Laureys, Genevieve ;

Schulte, Johannes H. ;

Schramm, Alexander ;

Van den Broecke, Caroline ;

Vermeulen, Joelle ;

Van Roy, Nadine ;

Beiske, Klaus ;

Renard, Marleen ;

Noguera, Rosa ;

Delattre, Olivier ;

Janoueix-Lerosey, Isabelle ;

Kogner, Per ;

Martinsson, Tommy ;

Nakagawara, Akira ;

Ohira, Miki ;

Caron, Huib ;

Eggert, Angelika ;

Cools, Jan ;

Versteeg, Rogier ;

Speleman, Frank .

CLINICAL CANCER RESEARCH, 2010, 16 (17) :4353-4362

← 1 2 3 4 5 6 →